Treatment of food intolerance and food allergy with IgM
OwnerMichael R. Simoninventor
Life of this patent
Estimating the term…
Abstract
A process is provided for inhibiting symptoms of food allergy or food intolerance in a subject that includes the oral administration to the subject suffering from food allergy or food intolerance an IgM. When administered in a therapeutic quantity based on the subject characteristics and the type of IgM, symptoms of food allergy or food intolerance in that subject are inhibited. Even non-secretory forms of IgM are effective when administered orally.
Claims12
A process for inhibiting symptoms of food allergy or food intolerance in a subject comprising:
- administering orally to the subject suffering from food allergy or food intolerance an IgM;
- and
- allowing sufficient time for said IgM to inhibit symptoms of food allergy or food intolerance in that subject wherein the food intolerance causes or exacerbates irritable bowel syndrome.
A process for inhibiting symptoms of food allergy or food intolerance in a subject comprising:
- administering orally to the subject suffering from food allergy or food intolerance an IgM;
- and
- allowing sufficient time for said IgM to inhibit symptoms of food allergy or food intolerance in that subject wherein the wherein food intolerance causes Food Protein-Induced Enterocolitis Syndrome (FPIES).
A process for inhibiting symptoms of food intolerance in a subject comprising:
- administering orally to the subject suffering from food intolerance a compound consisting essentially of:
- purified IgM;
- and
- allowing sufficient time for said purified IgM to inhibit symptoms of food intolerance in that subject wherein a food that induces the food intolerance is present in food selected from the group consisting of:
- milk, peanut, a tree nut, a cauliforate, a gluten containing grain crop, cheese, egg, shellfish, fish;
- and fruits.
A process for inhibiting symptoms of food intolerance in a subject comprising:
- administering orally to the subject suffering from food intolerance a purified IgM;
- and
- allowing sufficient time for said purified IgM to inhibit symptoms of food intolerance in that subject, wherein said IgM is bound to secretory component.
Dependencies are inferred from the claim text.